TR
Therapeutic Areas
Arcus Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Casdatifan | Late-line Kidney Cancer | Phase 3 |
| Inflammation Programs | Not Specified | Not Specified |
Leadership Team at Arcus Biosciences
JJ
Juan Jaen, PhD
President
JJ
Jennifer Jarrett
Chief Operating Officer
BG
Bob Goeltz
Chief Financial Officer
RM
Richard Markus, MD, PhD
Chief Medical Officer
DB
Dietmar Berger, MD, PhD
Board of Directors Member
KF
Kathryn Falberg
Board of Directors Member
LH
Linda Higgins, PhD
Board of Directors Member
YK
Yasunori Kaneko, MD
Board of Directors Member
DL
David Lacey, MD
Board of Directors Member
JA
Jeffrey A. Bluestone, PhD
Scientific Advisory Board Chairman